| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3774 | Nsc57971 | Novel non-peptide disruptor of IKKß/NEMO complex |
|
| DCC3775 | Nsc-60339 | Novel efflux pump inhibitor (EPI) |
|
| DCC3776 | Nsc61610 | Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator |
|
| DCC3777 | Nsc-627757 | Novel DNA repair inhibitor |
|
| DCC3778 | Nsc636795 | Novel inhibitor of ABCG2 transporter function |
|
| DCC3779 | Nsc-657186 | Novel selective non-zinc-binding MMP-2 inhibitor |
|
| DCC3780 | Nsc65847 | Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase |
|
| DCC3781 | Nsc66098 | Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein |
|
| DCC3782 | Nsc663627 | IκBα phosphorylation inhibitor |
|
| DCC3783 | Nsc-670224 | Toxitant of Saccharomyces_cerevisiae>Saccharomyces cerevisiae |
|
| DCC3784 | Nsc-672121 | Potent CDC25A>Cdc25A inhibitor; Vitamine K3 analogue |
|
| DCC3785 | Nsc-674205 | Potent and selective nociceptin opioid receptor (NOP) agonist |
|
| DCC3786 | Nsc676914a | Novel NF-κB inhibitor |
|
| DCC3787 | nsc-681152 | Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27(Kip1) ubiquitination in vitro |
|
| DCC3788 | Nsc-689857 | Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27Kip1 ubiquitination in vitro |
|
| DCC3789 | Nsc704342 | Novel Inhibitor of HCV NS3/4A Proteinase |
|
| DCC3790 | Nsc705841 | Novel selective serotonin reuptake inhibitor (SSRI), exhibiting higher binding affinities in comparison with the paroxetine |
|
| DCC3791 | Nsc724526 | Novel Inhibitor of HCV NS3/4A Proteinase |
|
| DCC3792 | Nsc724527 | Novel Inhibitor of HCV NS3/4A Proteinase |
|
| DCC3793 | Nsc-73306 | Cytotoxic MDR-selective ligand |
|
| DCC3794 | Nsc-741909 | Novel anticancer agent, suppressing the growth of several cell lines derived from lung, colon, breast, ovarian, and kidney cancers |
|
| DCC3795 | Nsc745885 | Novel down-regulator of EZH2, inducing G2/M cell-cycle arrest of cancer cells and degradating p53 via proteasome-dependent and -independent pathways |
|
| DCC3796 | nsc746364 | Telomerase inhibitor, stabilizing G-quadruplex and suppressing cell growth of A549 human lung cancer cells through activation of the ATR/Chk1-dependent pathway |
|
| DCC3797 | nsc746365 Maleate | Telomerase inhibitor, anticancer agent |
|
| DCC3798 | Nsc747854 | Novel inhibitor of poly (ADP-ribose) polymerase-1 (PARP-1) |
|
| DCC3799 | Nsc750212 | Novel inhibitor of lipid metabolism, disrupting tubulin polymerization,suppressing monoglycerol metabolism depleting lipids and inhibiting the growth of both lymphoma and RCC both in vitro and in vivo |
|
| DCC3800 | Nsc-77053 | The first reported BoNT/E small molecule inhibitor |
|
| DCC3801 | Nsc-79887 | Novel inhibitor of nucleoside hydrolase (NH) |
|
| DCC3802 | Nsc-80141 | Selective inhibitor of HsEg5 |
|
| DCC3803 | Nsc-84096 | Potent inhibitor of endopeptidase activity of botulinum neurotoxin type A light chain (rBoNT/A-LC) |
|
